Status:
COMPLETED
The Effects of Topical Calcium Glycerophosphate on Surgical Wound Healing and Residual Scarring
Lead Sponsor:
AkPharma Inc.
Collaborating Sponsors:
Rothman Institute Orthopaedics
Texas Tech University Health Sciences Center
Conditions:
Wound Healing
Scarring
Eligibility:
All Genders
45-75 years
Phase:
NA
Brief Summary
The purpose of this study is to determine whether topical application of calcium glycerophosphate will result in superior wound appearance and scar minimization.
Eligibility Criteria
Inclusion
- Informed consent must be obtained
- 45-75 years of age
- Scheduled for bilateral knee replacement surgery
Exclusion
- Employee or immediate family of either AkPharma or employee or immediate family of investigator or site personnel
- Pregnant or breast feeding Known allergy or hypersensitivity to calcium or phosphorus supplements
- Diagnosed with type I or type II diabetes mellitus
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01264588
Start Date
April 1 2008
End Date
December 1 2010
Last Update
December 22 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rothman Institute Orthopaedics
Egg Harbor, New Jersey, United States, 08234